Florida launches AI cancer fight: custom treatments for tough cases
NCT ID NCT07167381
Summary
This Florida-based study is testing a new AI-powered approach to find personalized treatments for cancer patients whose disease has returned or stopped responding to standard therapies. It aims to serve 210 patients, with a special focus on reaching children and underserved communities. Doctors will test how patients' own cancer cells respond to different drugs in the lab, then use AI to recommend the most promising treatment options for their specific case.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Ascent Biomedical
RECRUITINGMiami, Florida, 33183, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Florida International University
ACTIVE_NOT_RECRUITINGMiami, Florida, 33199, United States
Conditions
Explore the condition pages connected to this study.